We are live on ! Find out more
DCM

Dupont Capital Management Portfolio holdings

AUM $2.18M
1-Year Est. Return 50.81%
This Fund
S&P 500
This Quarter Est. Return
+9.08%
1 Year Est. Return
+50.81%
3 Year Est. Return
+136.7%
5 Year Est. Return
+194.47%
10 Year Est. Return
+665.34%
AUM
$4.46B
AUM Growth
+$109M
Cap. Flow
-$222M
Cap. Flow %
-4.98%
Top 10 Hldgs %
33.46%
Holding
1,348
New
162
Increased
437
Reduced
482
Closed
111

Sector Composition

Rank Sector Weight
1 Technology 12.1%
2 Financials 11.27%
3 Industrials 11.18%
4 Healthcare 8.27%
5 Consumer Discretionary 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPD icon
1001
Rapid7
RPD
$929M
$355K 0.01%
6,337
TGNA
1002
DELISTED
TEGNA Inc
TGNA
$355K 0.01%
21,259
-5,621
-21% -$87.5K
RETA
1003
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$355K 0.01%
1,736
-1,786
-51% -$326K
WLY icon
1004
John Wiley & Sons Class A
WLY
$2.63B
$353K 0.01%
7,284
-1
-0% -$46
ACHC icon
1005
Acadia Healthcare
ACHC
$2.82B
$352K 0.01%
10,603
+1,343
+15% +$42.1K
SD icon
1006
SandRidge Energy
SD
$516M
$352K 0.01%
83,103
-500
-0.6% -$2.09K
TKR icon
1007
Timken Company
TKR
$9.1B
$352K 0.01%
6,250
-859
-12% -$43.4K
DFS
1008
DELISTED
Discover Financial Services
DFS
$350K 0.01%
4,128
+1,070
+35% +$88.3K
LEN icon
1009
Lennar Class A
LEN
$21.1B
$350K 0.01%
6,477
+233
+4% +$13.3K
AERI
1010
DELISTED
Aerie Pharmaceuticals
AERI
$349K 0.01%
14,422
SBRA icon
1011
Sabra Healthcare REIT
SBRA
$5.15B
$348K 0.01%
16,300
-2,239
-12% -$50.1K
XNCR icon
1012
Xencor
XNCR
$1.71B
$346K 0.01%
10,059
NPKI
1013
NPK International
NPKI
$1.18B
$346K 0.01%
55,237
PZN
1014
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$343K 0.01%
39,753
+38,853
+4,317% +$335K
ENSG icon
1015
The Ensign Group
ENSG
$10.6B
$342K 0.01%
7,532
-520
-6% -$21.9K
FOLD
1016
DELISTED
Amicus Therapeutics
FOLD
$341K 0.01%
35,008
HIG icon
1017
Hartford Financial Services
HIG
$37.8B
$341K 0.01%
5,604
+1,416
+34% +$85K
ARCH
1018
DELISTED
Arch Resources, Inc.
ARCH
$341K 0.01%
+4,760
New +$365K
CLVS
1019
DELISTED
Clovis Oncology, Inc.
CLVS
$340K 0.01%
+32,610
New +$237K
CHRS icon
1020
Coherus Oncology
CHRS
$176M
$339K 0.01%
18,837
ENOV icon
1021
Enovis
ENOV
$1.48B
$339K 0.01%
5,414
+1,056
+24% +$59.7K
MXIM
1022
DELISTED
Maxim Integrated Products
MXIM
$338K 0.01%
5,500
-8,975
-62% -$523K
CPB icon
1023
Campbell Soup
CPB
$6.94B
$336K 0.01%
6,799
+1,762
+35% +$83.5K
MTDR icon
1024
Matador Resources
MTDR
$6.39B
$336K 0.01%
18,704
-2,570
-12% -$38.4K
RMD icon
1025
ResMed
RMD
$32.9B
$336K 0.01%
2,166
+500
+30% +$72.1K

Similar funds

Dupont Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Dupont Capital Management held 1,348 positions worth $4.46B, up 2.5% from $4.36B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Dupont Capital Management withdrew a net $222M in Q4 2019, closing 111 positions and reducing 482 holdings. Its most notable exit was Celgene Corp, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

Against the trend, Dupont Capital Management opened a new position in iShares MSCI ACWI ETF worth $7.1M.

  • Dupont Capital Management's largest Q4 2019 buy was iShares MSCI ACWI ETF: 89,613 shares worth $7.1M.
  • Dupont Capital Management added most to iShares MSCI EAFE ETF in Q4 2019, an estimated $29M increase.
  • Dupont Capital Management's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $212M.
  • Dupont Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $13.1M.
  • Dupont Capital Management's ten largest holdings make up 33% of its $4.46B portfolio in Q4 2019.
  • Dupont Capital Management opened 162 new positions and closed 111 in Q4 2019.
  • Dupont Capital Management's portfolio value rose 2.5% quarter-over-quarter to $4.46B.

Based on Dupont Capital Management's 13F filing for Q4 2019, filed 27 Jan 2020.